PFIZER INC Increase (Decrease) in Inventories
PFIZER INC (PFE) reported Increase (Decrease) in Inventories of -$561.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-02-26
- PFIZER INC increase (decrease) in inventories for the quarter ending 2023-12-31 was -$31.00M.
- PFIZER INC increase (decrease) in inventories for fiscal 2025 was -$561.00M, a 165.69% decline from fiscal 2024.
- PFIZER INC increase (decrease) in inventories for fiscal 2024 was $854.00M, a 26.95% decline from fiscal 2023.
- PFIZER INC increase (decrease) in inventories for fiscal 2023 was $1.17B, a 97.80% increase from fiscal 2022.
- PFIZER INC increase (decrease) in inventories for fiscal 2022 was $591.00M, a 47.47% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | -$561.00M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $854.00M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | -$31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.17B 10-K · filed 2026-02-26 | ||
| 2023-10-01 | $1.20B 10-Q · filed 2023-11-08 | |||
| 2022-12-31 | $591.00M 10-K · filed 2025-02-27 | -$592.00M 10-K · filed 2023-02-23 | ||
| 2021-12-31 | $1.13B 10-K · filed 2024-02-22 | |||
| 2020-12-31 | $778.00M 10-K · filed 2023-02-23 | $736.00M 10-K · filed 2021-02-25 | ||
| 2019-12-31 | $1.07B 10-K · filed 2022-02-24 | $1.05B 10-K · filed 2020-02-27 | ||
| 2018-12-31 | $432.00M 10-K · filed 2021-02-25 | $717.00M 10-K · filed 2019-02-28 | ||
| 2017-12-31 | $357.00M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | -$365.00M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $199.00M 10-K · filed 2018-02-22 | |||
| 2014-12-31 | -$175.00M 10-K · filed 2017-02-23 | |||
| 2013-12-31 | $538.00M 10-K · filed 2016-02-29 | |||
| 2012-12-31 | $631.00M 10-K · filed 2015-02-27 | |||
| 2011-12-31 | -$1.08B 10-K · filed 2014-02-28 | |||
| 2010-12-31 | -$2.92B 10-K · filed 2013-02-28 | |||
| 2009-12-31 | -$1.63B 10-K · filed 2012-02-28 | |||
| 2008-12-31 | -$294.00M 10-K · filed 2011-02-28 | |||
| 2007-12-31 | -$720.00M 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |